Common sleep aid blocks brain inflammation and tau buildup in Alzheimer's model

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer's model

A recent study published in Nature Neuroscience provides evidence that lemborexant, a medication used to treat insomnia, can reduce brain damage linked to Alzheimer’s disease in a mouse model. The drug helped restore more normal sleep patterns and limited the buildup of tau, a protein known to damage neurons. The findings raise the possibility that medications targeting the brain’s sleep-wake system could one day help prevent or slow the progres…